Based on previous studies in other patient populations, we estimated that our study would reveal at least a two-fold greater risk of serious skin and soft tissue infections among VA hospital rheumatoid arthritis patients receiving anti - TNF drug therapy, yet we saw no significant association between anti- TNF therapy and increased SSSTI risk. Here, TNF is linked to rheumatoid arthritis.